Effects of short-term hormone replacement on atherogenic indices in Indian postmenopausal women

Indian Journal of Clinical Biochemistry

Volumn 21, Issue 1, 2006, Pages 41-47

  Arora, Sarika ^a   Jain, Anju ^a   Chitra, R ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Apo B Apo A1; Conjugated estrogens; LDL HDL Ratio; Medroxyprogesterone acetate; Total cholesterol HDL

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HEART PROTECTION; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INDIAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; NIGHT SWEAT; PHASE 3 CLINICAL TRIAL; POSTMENOPAUSE; SHORT COURSE THERAPY; SINGLE BLIND PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL; VAGINA BLEEDING; VENOUS BLOOD;

EID: 33644917779     PISSN: 09701915     EISSN: 09701915     Source Type: Journal    
DOI: 10.1007/BF02913065     Document Type: Article

References (23)

1. th Edition; Williams and Wilkins Publishers, USA, p 583-649.
2. Benagiano, G. and Primiero FM (2003) Menopause, a Global perspective; Reprod. Biomed Online 2 (3), 204-211.
3. Tchernof, A., Poelhman, E.T. and Despr'es, J.P. (2000) Body Fat distribution, the menopause transition and Hormone Replacement Therapy; Diabetes Metab. 26 (1), 12-20.
4. Kornowski, R., Lansky, A.J., Mintz, G.S., Kent, K.M., Pichard, A.D., Satler, L.F. et al. (1997) Comparison of men versus women in cross-sectional area, luminal narrowing, quantity of plaque, presence of calcium in plaque, and lumen location in coronary arteries by intravascular ultrasound in patients with stable angina pectoris. Am J Cardiol. 79, 1601-1605.
5. Enas, A., Enas, A., Senthilkumar, Vijaya Juturu and Gupta, Rajeev (2001) Coronary Artery Disease in women. Indian Heart J. 53, 282-292.
6. Daniel, J., Rader, Michael, Davidson, H., Richard. J., Caplan and John S. Pears (2003) Lipid and Apolipoprotein Ratios: Association with Coronary Artery disease and effects of Rosuvastatin Compared with Atorvastatin, Pravastatin, and Simvastatin. American Journal of Cardiology 91 (5A), 20C-24C.
7. Michael Gaziano, J., Charles, H. Hennekens, Christopher, J., O'Donnell, Jan L., Breslow and Julie E. Buring (1997) Fasting Triglycerides, High Density Lipoproteins and the risk of Myocardial Infarction. Circulation 96, 2520-2525.
8. Kuttenn, F., Gerson, M., and de Ligneres, B. (2002) Effects of hormone replacement therapy in menopause on cardiovascular risk. Need for a European study. Presse Med. 31 (10), 468-475.
9. Turpin, G. (1994) Role of hormone replacement therapy during menopause in the cardiovascular prevention. Ann. Cardiol. Angelol. (Paris) 43 (3), 177-180.
10. Oya, Gökman, Elif, G . and Yapar, Eyi (1999) Hormone Replacement Therapy and lipid - lipoprotein concentrations; Eur. J. of Obstet. Gynaecol. & Reprod. Biol. 85, 31-41.
11. Ariyo, A.A. and Villablanca, A.C. (2002) Estrogens and lipids: Can HRT, designer estrogens, and phytoestrogens reduce cardiovascular risk markers after menopause? Postgrad. Med. 111 (1), 23-30
12. Writing Group for the PEPI Trial (1995), Effects of Estrogen or Estrogen / Progestin Regimens on Heart Disease Risk factors in Postmenopausal Women. JAMA 273 (3), 199 -208.
13. Lobo, R.A., Pickar, J.H., Wild, R.A., Walsh, B., Hirvonen, E. for the Menopause Study Group (1994) Metabolic impact of adding medroxyprogesterone acetate to conjugate estrogen therapy in postmenopausal women. Obstet. Gynaecol. 84, 987-995.
14. Rijpkema, A.H., van der Sanden, A.A. and Ruijs, A.H. (1990) Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review. Maturitas 12 (3), 259-285.
15. Lafferty, F.W. and Fiske, M.E. (1994) Postmenopausal estrogen replacement; a long term cohort study. Am. J. Med. 97, 66-77.
16. Kim, Ch. J., Min, Y.K., Ryu, W.S. et al. (1996) Effect of hormone replacement therapy on lipoprotein (a) and lipid levels in postmenopausal women. Arch. Intern. Med. 156, 1693-1700.
17. Everson, G.T., McKinley, C. and Kern, F. Jr. (1991) Mechanisms of gallstone formation in women: effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J. Clin. Invest. 87 (1), 237-246.
18. vander Mooren, M.J., Leuven, J.A. and Rolland, R. (1994), Effect of conjugated estrogens with and without medrogestone; a prospective study. Maturitas 19 (1), 33-42.
19. Miller, V.T., Muesing, R.A., La Rosa, J.C., Stoy, D.B., Phillips, E.A. and Stillman, R.J. (1991) Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high density lipoprotein sub fractions and Apolipoprotein A1. Obstet. Gynaecol. 77 (2), 235-240.
20. Pancini, F., Bergamini, C., Bettocchi, S. Jr., Bassi, P., Malfaccini, M. and Bagn, G. (1984) Short-term effect of oophorectomy on lipoprotein metabolism. Gynaecol. Obstet. Invest. 18 (3), 134-139.
21. Sanada, M., Nakagawa, H., Kodama, I., Sakasita, T. and Ohama, K. (2000) The effect of Hormone Replacement Therapy on metabolism of lipoprotein remnants in postmenopausal women. Maturitas 34 (1), 75-82.
22. Writing Group For the Women's Health Initiative (2002) Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal women. JAMA, 288 (3), 321-333.
23. Rosano, G.M. and Fini, M. (2002) Postmenopausal women and cardiovascular risk; impact of hormone replacement therapy. Cardiol. Rev. 10 (1), 51-60.